ConductScience.org, home

Paper48003

Metronidazole for Crohn's disease.

Ursing B and 1 other. Lancet, 1975. Cited by 207 papers, by iCite.

Cite this record

ConductScience Library. Metronidazole for Crohn's disease. Papers, record 48003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/48003

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metronidazole for Crohn's disease.
PubMed
Journal
Lancet
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
207
iCite
Relative citation ratio, by iCite
10.6
iCite
Revised in PubMed
2019-06-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ursing BB
2Kamme CC

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Crohn DiseaseMajor topic
MetronidazoleMajor topic
Adult
Child
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
Humans
Hyperesthesia
Male
Paresthesia
Prednisolone
Sulfasalazine

Source PubMed

Download CSV of topics

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 207 citations.

PMIDTitleJournalYearIn PapersSource
35198041A review of the therapeutic management of Crohn's disease.Ther Adv Gastroenterol2022https://conductscience.org/library/papers/35198041PubMed
17948930Role of bacteria in the etiopathogenesis of inflammatory bowel disease.World J Gastroenterol2007https://conductscience.org/library/papers/17948930PubMed
17066156Antibiotic therapy for Crohn's disease: a review.Can J Gastroenterol2006https://conductscience.org/library/papers/17066156PubMed
10980989Prevention of postoperative recurrence in Crohn's disease.Curr Gastroenterol Rep1999https://conductscience.org/library/papers/10980989PubMed
10636100Risk factors for surgery and postoperative recurrence in Crohn's disease.Ann Surg2000https://conductscience.org/library/papers/10636100PubMed
9360057Metronidazole. A therapeutic review and update.Drugs1997https://conductscience.org/library/papers/9360057PubMed
8568400Management of rectourethral fistulas in Crohn's disease.Int J Colorectal Dis1995https://conductscience.org/library/papers/8568400PubMed
8307475Faecal diversion for Crohn's colitis: a model to study the role of the faecal stream in the inflammatory process.Gut1994https://conductscience.org/library/papers/8307475PubMed
7251906Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals.J Clin Pathol1981https://conductscience.org/library/papers/7251906PubMed
6757043Idiopathic Inflammation Bowel Disease: is there a role for immunological mechanisms in etiopathogenesis?Gastroenterol Jpn1982https://conductscience.org/library/papers/6757043PubMed
6363218Inflammatory bowel disease in childhood.Gut1984https://conductscience.org/library/papers/6363218PubMed
3771623Carcinogenicity, perinatal carcinogenicity and teratogenicity of low dose metronidazole (MNZ) in Swiss mice.J Cancer Res Clin Oncol1986https://conductscience.org/library/papers/3771623PubMed
2253542Closure of refractory perineal Crohn's lesion. Integration of hyperbaric oxygen into case management.Dig Dis Sci1990https://conductscience.org/library/papers/2253542PubMed
1916494Double blind, placebo controlled trial of metronidazole in Crohn's disease.Gut1991https://conductscience.org/library/papers/1916494PubMed
1676590Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.Drug Saf1991https://conductscience.org/library/papers/1676590PubMed
1174915Letter: Brain abscess.Br Med J1975https://conductscience.org/library/papers/1174915PubMed
912357Metronidazole neuropathy.Br Med J1977https://conductscience.org/library/papers/912357PubMed
730070Mucosal-associated bacterial flora of the intestine in patients with Crohn's disease and in a control group.Gut1978https://conductscience.org/library/papers/730070PubMed
60419514C-Glycocholate test in Crohn's disease--its value in assessment and treatment.Gut1977https://conductscience.org/library/papers/604195PubMed
487957Treatment of infections due to nonsporing anaerobes.Drugs1979https://conductscience.org/library/papers/487957PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/48003

GET https://conductscience.org/api/papers/v1/48003/cited_by?page=2